Lazard Capital Starts Repros Therapeutics (RPRX) at Buy

February 5, 2013 6:40 AM EST
Get Alerts RPRX Hot Sheet
Price: $2.37 -2.07%

Rating Summary:
    4 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 54 | New: 6
Trade RPRX Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $26.00.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $11.83 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Lazard

Add Your Comment